Oksana Kaidanovich-Beilin

Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus.

Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha.

Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.

Peptides targeting protein kinases: strategies and implications.

Abnormalities in brain structure and behavior in GSK-3alpha mutant mice.

Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.

Selective loss of glycogen synthase kinase-3α in birds reveals distinct roles for GSK-3 isozymes in tau phosphorylation.

Genetic inactivation of GSK3α rescues spine deficits in Disc1-L100P mutant mice.

GSK-3: Functional Insights from Cell Biology and Animal Models.